Maturana-Ramiìrez A, Aitken-Saavedra J, Rojas-Zúñiga G, Rojas-Alcayaga G, Espinoza-Santander I, Rebolledo A, Fuentes R, Reyes-Rojas M, Araya C, Lazo D, Caamaño E
Department of Oral Pathology and Medicine Faculty of Dentistry, Universidad de Chile 8380492 Olivos 943, Independencia, Santiago, Chile
Med Oral Patol Oral Cir Bucal. 2025 Jan 1;30(1):e24-e30. doi: 10.4317/medoral.26692.
Hypovitaminosis D raised a significant public health concern due to its potential association with various diseases, including Oral Squamous Cell Carcinoma (OSCC). The objective of this study was to compare serum 25(OH)D3 levels between individuals with and without OSCC, and by subgroups based on their smoking habits.
A case-control study was conducted utilizing progressive multicenter recruitment, involving 46 patients with Oral Squamous Cell Carcinoma (OSCC) and 65 controls. Serum levels of 25(OH)D3 were evaluated via electrochemiluminescence. Patients were categorized according to their vitamin D levels into sufficiency, mild deficiency, moderate deficiency, and severe deficiency. Comparative analyses of serum 25(OH)D3 levels were performed between OSCC patients and controls, as well as among subgroups based on their smoking habits. Group comparisons were made with the Mann-Whitney test, and subgroup analyses used the Kruskal-Wallis test. Significance was set at p < 0.05 Results: 91% of participants, including both OSCC patients and controls, exhibited some degree of 25(OH)D3 deficiency. Among them, 71.7% of OSCC patients and 50.7% of controls had serum levels characterized by moderate to severe deficiencies. Patients with OSCC showed lower levels of 25(OH)D3, with medians of 20.2 ng/ml (IQR 9.48), compared to controls, with medians of 24.8 ng/ml (IQR 9.13) (p=0.002). Furthermore, when comparing the medians among the four study groups (smoking and non-smoking controls and smoking and non-smoking patients with OSCC), a significant difference was observed between non-smoking control patients with 25.04 ng/ml (IQR = 9.71) and smoking OSCC patients with 19.65 ng/ml (IQR = 12.14) (p < 0.05).
Individuals with oral squamous cell carcinoma (OSCC) exhibited lower serum levels of vitamin D (25(OH)D3) compared to controls, suggesting a potential link between vitamin deficiency and the development of this type of cancer. Vitamin D supplementation could serve as a preventive and therapeutic strategy.
维生素D缺乏因其与包括口腔鳞状细胞癌(OSCC)在内的多种疾病的潜在关联而引发了重大的公共卫生问题。本研究的目的是比较患有和未患有OSCC的个体之间以及根据吸烟习惯分组的亚组之间的血清25(OH)D3水平。
采用逐步多中心招募进行了一项病例对照研究,涉及46例口腔鳞状细胞癌(OSCC)患者和65例对照。通过电化学发光法评估血清25(OH)D3水平。患者根据维生素D水平分为充足、轻度缺乏、中度缺乏和重度缺乏。对OSCC患者和对照之间以及根据吸烟习惯分组的亚组之间的血清25(OH)D3水平进行了比较分析。组间比较采用Mann-Whitney检验,亚组分析采用Kruskal-Wallis检验。显著性设定为p < 0.05。结果:包括OSCC患者和对照在内的91%的参与者表现出一定程度的25(OH)D3缺乏。其中,71.7%的OSCC患者和50.7%的对照血清水平为中度至重度缺乏。OSCC患者的25(OH)D3水平较低,中位数为20.2 ng/ml(四分位间距9.48),而对照的中位数为24.8 ng/ml(四分位间距9.13)(p = 0.002)。此外,在比较四个研究组(吸烟和不吸烟对照以及吸烟和不吸烟的OSCC患者)的中位数时,观察到不吸烟对照患者的中位数为25.04 ng/ml(四分位间距 = 9.71)与吸烟的OSCC患者的中位数为19.65 ng/ml(四分位间距 = 12.14)之间存在显著差异(p < 0.05)。
与对照相比,口腔鳞状细胞癌(OSCC)患者的血清维生素D(25(OH)D3)水平较低,表明维生素缺乏与这种类型癌症的发生之间可能存在联系。补充维生素D可作为一种预防和治疗策略。